This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The principle (intention to treat or treatment completers only) used in the analysis of effectiveness was not explicitly specified. The primary health outcomes used in the analysis were complications in the surgical intensive care unit (SICU), number of days in the SICU and the hospital, morbidity measured by Acute Physiology and Chronic Health Evaluation (APACHE) II score at admission and discharge (gauging severity of illness) and by the Hunt-Hess (HH) grade at admission and immediately preoperatively (gauging severity of neurological insult), quality of life (QOL) score, complications, and mortality. Multiple regression analysis was performed to identify the variables having close correlation with QOL score.
Effectiveness results
The most common complication in the group aged under 65 years was hypertension (n=57) followed by cerebral vasospasm (n=40) and arrhythmia (n=26). The corresponding figures for the group aged over 65 years were 20, 6 and 5. The duration of SICU care, which ranged from 4 to 10.5 days, was estimated not to differ by decade of age. However, with the 65-year-based division, the group aged over 65 had significantly more SICU days (10.5 (range:1 -45) days versus 5 (range: 1 -60) days, p=0.008). The duration of hospitalisation before operation was 3 days (range: 0 -24, p=0.017) in the over 65 group and 2 days (range: 0 -65) in under 65 group. The mortality rate was 4.6% (under 65s) and 13% (p=0.008) (over 65s). In terms of decade of age, the mortality rate ranged from 3% in the 50 to 59 years category to 17% in the 70 to 81 years category. The differences across the subgroups were not significant except for the 70 to 81 years category compared with the 50 to 59 years category. The APACHE score at discharge ranged from 3 in the 23 to 39 years category to 10 in the 70 to 79 years category. The corresponding values for the under and over 65 years groups were 5 to 10, (p<0.05). HH grade at operation ranged from 2 in the 40 to 49 years category to 3 in the 70 to 79 years category. QOL score ranged from 1 in the 23 to 39 years category to 2 in the 60 to 69 years category. The corresponding values for the under and over 65 years groups were 1 and 2, (p<0.01).
Clinical conclusions
Clinical grade, as represented by HH score, did not differ by age, which suggests that the severity of the SAH was a more important determinant than age. APACHE II scores, however, did vary by age. Therefore, it was surprising that the number of complications or duration of hospitalisation did not differ by age. This emphasises that, where risk related to comorbidity can be greater for the elderly, this is not a given.
Measure of benefits used in the economic analysis
No summary benefit measure was identified in the economic analysis, and only separate clinical outcomes were measured.
Direct costs
Discounting was not undertaken due to the short period of follow-up. Quantities were analysed separately from costs. Hospital and SICU costs were included in the analysis. The quantity/cost boundary adopted was the hospital (tertiary care centre). The direct costs included non-medical overhead costs in addition to the direct medical costs identified above. The price year was not stated.
